Clinical trial · Observational
Intraoperative Hyperspectral Imaging for Fluorescence Guided Surgery in Low Grade Gliomas
Intraoperative Hyperspectral Imaging for Real-time Fluorescence-guided Surgery of Low Grade Glioma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to obtain images of brain tumours during surgery using a new type of surgical camera. The study will assess how the information obtained from the images during surgery matches the removed tissue. Data will also be used to develop the system's key computer-processing features. This will enable real-time information to be given to the surgeon whilst they are performing the procedure and has the potential to make neurosurgery safer and more precise.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Tumor | Brain Neoplasm | ALIAS | 0.90 |
| Neuro-Oncology | — | UNRESOLVED | — |
| Neurosurgery | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Correlation of qFHSI data with histological analysis of the corresponding biopsied pathological tissue
- timeFrame
- 6-12 months
- description
- To correlate ex vivo and in vivo qFHSI data with histological analysis of the corresponding biopsied glioma tissue
Secondary outcomes (4)
- measure
- Safety of qFHSI in surgery
- timeFrame
- 24-36 months
- description
- To demonstrate safety of our intraoperative qFHSI device during glioma surgery
- measure
- Tissue diagnosis
- timeFrame
- 24 months
- description
- To collect ex vivo and in vivo qFHSI data during glioma surgery for tissue analysis, algorithmic development and testing
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patients aged 18 years and over * Patients with a diagnosis of a probable glioma (any grade), who are scheduled for elective surgery * Patients able to provide written informed consent Exclusion Criteria: * Patients under 18 years of age * Patients who have previously had brain surgery * Patients unable to provide written informed consent
References
Publications (0)
Data not yet available